Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells
Open Access
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (5) , 976-986
- https://doi.org/10.1016/j.ymthe.2005.11.018
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration AbilityJournal of Virology, 2005
- New therapies for muscular dystrophy: cautious optimismTrends in Molecular Medicine, 2004
- Nucleofection of muscle-derived stem cells and myoblasts with ϕC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblastsMolecular Therapy, 2004
- Helper-Dependent Adenoviral Vectors Containing Modified Fiber for Improved Transduction of Developing and Mature Muscle CellsHuman Gene Therapy, 2004
- Adenovirus Type 11 Uses CD46 as a Cellular ReceptorJournal of Virology, 2003
- Efficient Generation and Amplification of High-Capacity Adeno-Associated Virus/Adenovirus Hybrid VectorsJournal of Virology, 2002
- Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of DiseaseJournal of Virology, 2002
- Highly Efficient Targeted Transduction of Undifferentiated Human Hematopoietic Cells by Adenoviral Vectors Displaying Fiber Knobs of Subgroup BHuman Gene Therapy, 2001
- Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral VectorsHuman Gene Therapy, 1996
- Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapySomatic Cell and Molecular Genetics, 1990